C.H. Robinson Worldwide Inc. agreed to buy RXO Inc. in a $5.8 billion deal, according to Bloomberg.

The transaction was described as AI-driven in the source headline, but the body provided no additional details beyond saying it is hard to ignore how AI motivated the move.